Enjoy complimentary customisation on priority with our Enterprise License!
The biomaterial wound dressing market share is expected to increase by USD 90.49 million from 2021 to 2026, and the market's growth momentum will accelerate at a CAGR of 6.11%.
This biomaterial wound dressing market research report provides valuable insights on the post COVID-19 impact on the market, which will help companies evaluate their business approaches. Furthermore, this report extensively covers biomaterial wound dressing market segmentation by type (antimicrobial dressings and bio-engineered skin and skin substitutes) and geography (North America, Europe, Asia, and Rest of World (ROW)). The biomaterial wound dressing market report also offers information on several market vendors, including 3M Co., AdvaCare International, B. Braun Melsungen AG, Baxter International Inc., Cardinal Health Inc., Coloplast Corp., DermaRite Industries LLC, Hollister Inc., Integra LifeSciences Corp., Johnson and Johnson Inc., Medline Industries Inc., Molnlycke Health Care AB, Nidhi Surgicals Pvt. Ltd., Paul Hartmann AG, Scapa Group Plc, Smith and Nephew plc, URGO Group, Vericel Corp., ConvaTec Group Plc, and Informa Plc among others.
Download the Free Report Sample to Unlock the Biomaterial Wound Dressing Market Size for the Forecast Period and Other Important Statistics
The increasing incidence of sports injuries and chronic wounds is notably driving the biomaterial wound dressing market growth, although factors such as strict regulatory compliances for biomaterial wound dressings may impede market growth. Our research analysts have studied the historical data and deduced the key market drivers and the COVID-19 pandemic impact on the biomaterial wound dressing industry. The holistic analysis of the drivers will help in deducing end goals and refining marketing strategies to gain a competitive edge.
Key Biomaterial Wound Dressing Market Driver
One of the key factors driving the global biomaterial wound dressing market growth is the increasing incidence of sports injuries and chronic wounds. Every year, about 4-5 million people aged 15 years or above avail treatments in European hospitals for sports-related injuries. In the US, high-school athletes account for 2-2.5 million injuries and 2.5 times doctor visits each year. These injuries in the US have increased by about 4-5 times during 2000-2020. In Australia, about 35,000-36,000 people undergo hospital treatment each year due to sports-related injuries such as fractures, ankle injuries, and hamstring strains. In addition, the high prevalence of diseases such as diabetes and paralysis has increased the number of chronic wound cases. According to The World Bank Group, as of 2020, 9% of the global population aged between 20 and 79 years had type 1 or type 2 diabetes. Such factors are expected to positively impact the market growth in the forecast period.
Key Biomaterial Wound Dressing Market Trend
Another key factor driving the global biomaterial wound dressing market growth is the significant demand from the geriatric population. For instance, globally, between 25% and 35% of fall incidents are recorded to occur in people aged 65 or above, which causes unintentional injuries. In the UK, Canada, and Australia, the rate of hospital admission of the geriatric population due to falls is 1-3 per 10,000 population. According to the CDC, in the US, fall incidents in older people account for 25% each year, and around 20% results in severe injuries. In addition, according to the CDC, in 2020, around 30% of people aged 65 years or above will suffer from diabetes in the US, and the prevalence of diabetes among the elderly is expected to increase significantly, which means that 16% of the world's population will be aged 65 years or above. Such factors are expected to further support the market growth in the forecast period.
Key Biomaterial Wound Dressing Market Challenge
One of the key challenges to the global biomaterial wound dressing market growth is the strict regulatory compliances for biomaterial wound dressings. Commercial wound care products must comply with regulatory requirements and standards defined by international and local regulatory authorities, such as the Food and Drug Administration (FDA), the European Medicine Agency (EMA), and the American Society for Testing and Materials (ASTM) International. For instance, surgical tapes must comply with internationally recognized standards, such as ASTM PSTC/6 standards by the member countries of ASTM International. Biomaterial wound dressings in the European market are regulated by the EMA and should comply with the Medical Devices Directive 93/42/EEC. Labeling specifications have been mentioned in Medical Devices Directive 93/42/EEC under Annex I paragraph 13. Variable statutory requirements and regional differences in the standardization of products are projected to hamper the operations of global wound care product manufacturers in the coming years.
This biomaterial wound dressing market analysis report also provides detailed information on other upcoming trends and challenges that will have a far-reaching effect on the market growth. The actionable insights on the trends and challenges will help companies evaluate and develop growth strategies for 2022-2026.
Technavio categorizes the global biomaterial wound dressing market as a part of the global pharmaceutical market. Our research report has extensively covered external factors influencing the parent market growth potential in the coming years, which will determine the levels of growth of the biomaterial wound dressing market during the forecast period.
The report analyzes the market's competitive landscape and offers information on several market vendors, including:
This statistical study of the biomaterial wound dressing market encompasses successful business strategies deployed by the key vendors. The biomaterial wound dressing market is fragmented and the vendors are deploying growth strategies such as business strategic alliances and collaborations to compete in the market.
To make the most of the opportunities and recover from post COVID-19 impact, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.
The biomaterial wound dressing market forecast report offers in-depth insights into key vendor profiles. The profiles include information on the production, sustainability, and prospects of the leading companies.
Our report provides extensive information on the value chain analysis for the biomaterial wound dressing market, which vendors can leverage to gain a competitive advantage during the forecast period. The end-to-end understanding of the value chain is essential in profit margin optimization and evaluation of business strategies. The data available in our value chain analysis segment can help vendors drive costs and enhance customer services during the forecast period.
For more insights on the market share of various regions Request for a FREE sample now!
43% of the market's growth will originate from North America during the forecast period. The US is the key market for biomaterial wound dressing in North America. Market growth in this region will be faster than the growth of the market in Europe and Rest of World (ROW).
The rise in prevalence of acute and chronic wounds, the increase in the number of surgical procedures, and the increase in the adoption of technologically advanced NPWT devices will facilitate the biomaterial wound dressing market growth in North America over the forecast period. This market research report entails detailed information on the competitive intelligence, marketing gaps, and regional opportunities in store for vendors, which will assist in creating efficient business plans.
COVID Impact and Recovery Analysis
The outbreak of COVID-19 negatively impacted the biomaterial wound dressing market in 2020 in North America, especially in the US, Canada, and Mexico. As a result, manufacturing units of various industries, including biomaterial wound dressing, were closed. This might negatively impact the growth of the biomaterial wound dressing market in North America during the first half of the forecast period. However, biomaterial wound dressings are majorly used by commercial, industrial, and individual users. Companies operating in the above-mentioned industries were categorized into essential services in 2020 during the pandemic. Therefore, the situation is expected to improve during the latter half of the forecast period, depending on the containment of the pandemic.
To gain further insights on the market contribution of various segments Request for a FREE sample
The biomaterial wound dressing market share growth by the antimicrobial dressings segment will be significant during the forecast period. Antimicrobial dressings are used for partial and full-thickness burns as well as burns of indeterminable depth in the initial stages of injury. These dressings are also used to prevent infections and treat localized wound infections in conjunction with systemic antibiotic treatment. Such factors are expected to drive the growth of the segment in focus in the coming years.
This report provides an accurate prediction of the contribution of all the segments to the growth of the biomaterial wound dressing market size and actionable market insights on post COVID-19 impact on each segment.
Biomaterial Wound Dressing Market Scope |
|
Report Coverage |
Details |
Page number |
120 |
Base year |
2021 |
Forecast period |
2022-2026 |
Growth momentum & CAGR |
Accelerate at a CAGR of 6.11% |
Market growth 2022-2026 |
$ 90.49 million |
Market structure |
Fragmented |
YoY growth (%) |
5.51 |
Regional analysis |
North America, Europe, Asia, and Rest of World (ROW) |
Performing market contribution |
North America at 43% |
Key consumer countries |
US, Germany, France, UK, and Japan |
Competitive landscape |
Leading companies, Competitive strategies, Consumer engagement scope |
Key companies profiled |
3M Co., AdvaCare International, B. Braun Melsungen AG, Baxter International Inc., Cardinal Health Inc., Coloplast Corp., DermaRite Industries LLC, Hollister Inc., Integra LifeSciences Corp., Johnson and Johnson Inc., Medline Industries Inc., Molnlycke Health Care AB, Nidhi Surgicals Pvt. Ltd., Paul Hartmann AG, Scapa Group Plc, Smith and Nephew plc, URGO Group, Vericel Corp., ConvaTec Group Plc, and Informa Plc |
Market dynamics |
Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, Market condition analysis for forecast period |
Customization purview |
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
We can help! Our analysts can customize this report to meet your requirements. Get in touch
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Five Forces Analysis
5 Market Segmentation by Type
6 Customer Landscape
7 Geographic Landscape
8 Drivers, Challenges, and Trends
9 Vendor Landscape
10 Vendor Analysis
11 Appendix
Get the report (PDF) sent to your email within minutes.
Get lifetime access to our
Technavio Insights
Quick Report Overview:
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.